EMEA-002617-PIP01-19
Submitted by Anonymous (not verified) on 10 July 2026 - 8:18
EMEA-002617-PIP01-19
EMEA-002617-PIP01-19
EMEA-002430-PIP01-18
EMEA-001556-PIP01-13
EMEA-001693-PIP03-21
Minutes - Enpr-EMA Coordinating Group meeting, April 2026
Agenda - EnprEMA Coordinating Group meeting, April 2026
Enpr-EMA Coordinating Group meeting April 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 April 2026, 14:00 (CEST) to 8 April 2026, 15:00 (CEST)
Article 57 product data
Human medicines European public assessment report (EPAR): Zavesca, miglustat, Date of authorisation: 20/11/2002, Date of refusal: 16/06/2009, Revision: 36, Status: Authorised
Human medicines European public assessment report (EPAR): Ztalmy, ganaxolone, Date of authorisation: 26/07/2023, Revision: 8, Status: Authorised